Product Images Gabapentin

Each capsule contains 100 mg of gabapentin, USP with an NDC code of 83301-0003-3. Dosage information is available in the package insert. Store the capsules at room temperature and dispense them in tight (USP) containers. The medication guide that accompanies each patient's prescription must be provided. Manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. in Shijiazhuang, Hebei, China. This information is valid until March 2023.*

This is a description of a medication called Gabapentin Capsules containing 100 mg of the active ingredient gabapentin, USP per capsule. The dosage information is referred to the package insert. The medication should be stored in a tight (USP) and child-resistant container at a controlled room temperature between 15° to 30°C (59° to 86°F). It is manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. in Shijiazhuang, Hebei, China, and distributed by Mullan Pharmaceutical Inc. in Pasadena, CA. The medication is available in packages of 100 capsules and should be dispensed by a pharmacist with a medication guide provided separately to each patient.*

This text appears to be a label of medication packaging for Gabapentin Capsules. It includes the dosage instructions and storage instructions. The manufacturer is Votan Pharmaceuticals. The label also mentions a prescription requirement for dispensing this medication.*

Each capsule of gabapentin contains 300 mg of gabapentin USP and has an NDC code of 83301-0004-3. Full USP prescribing information and storage instructions are available in the package insert. The capsules should be stored at 25°C (77°F) with excursions permitted from 15°C to 30°C (59°F to 86°F). The medication should be dispensed with a Medication Guide in tight (USP) containers from Mullan Pharmaceutical Inc. The capsules are manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. in Shijiazhuang, Hebei, China.*

The text contains information about the size of capsules, their content and dosage instructions. It also provides storage instructions and information about the manufacturer and supplier. Additionally, it indicates that Medication Guide should be given to each patient.*

This is a description of gabapentin capsules manufactured by CSPC Ouyi Pharmaceutical Co. Each capsule contains 300 mg of gabapentin, USP. The dosage information is available in the package insert. The capsules should be stored at 25°C with excursions permitted from 15° to 30°C. They should be dispensed in tight (USP) containers. The capsules are manufactured for Mullan Pharmaceutical Inc., based in Pasadena, CA and are available in a pack of 500 capsules. The accompanying medication guide should be provided separately to each patient by the pharmacist.*

Each capsule contains 400mg of gabapentin, USP. See package insert for full dosage information. The capsules should be stored in a tight (USP), child-resistant container at 25°C (77°F), with permitted excursions from 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. The product comes in a package of 100 capsules with dimensions of 18x50mm. It is manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. in Shijiazhuang, Hebei, China. The product is suitable for prescription.*

This is a description of a medication called Gabapentin Capsules. The capsules contain 400mg of gabapentin and come in a package with 500 capsules. The dosage information can be found in the package insert. The medication needs to be stored at 25°C (77°F) and can be stored at temperatures between 15°C to 30°C. It should be dispensed in tight (USP) containers. The medication is manufactured by CSPC Ouyi Pharmaceutical Co., Ltd in Shijiazhuang, Hebei, China. It's distributed by Mullan Pharmaceutical Inc. in Pasadena, California, and the accompanying Medication Guide should be handed to each patient by their pharmacist.*

The text is a chart showing the mean pain scores for a d-week dose titration period and a 4-week fixed dose period, with placebo and gabapentin at a dose of 3,600 mg/day as the treatments being compared. It is not available what pain condition or study this is referencing.*

This is a chart displaying the mean pain score for a study conducted over a 4-week fixed dose period. The study compared a placebo to two different doses of gabapentin (1,800 my/day and 2,400 my/day). The baseline score and scores at weeks 1, 2, 3, 5, 6, and 7 were recorded. The mean pain score was 10.*

The text appears to be a set of percentages followed by some statistical notation and references to two studies labeled as "Study 1" and "Study 2". Without further context, it is not possible to provide a more specific description of the content.*